World's Best Scientists 2026 revealed!
Gaston De Serres

Gaston De Serres

D-Index & Metrics

Immunology

D-Index
71
Citations
17023
World Ranking
2335
National Ranking
52

Gaston De Serres publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gaston De Serres sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 312 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gaston De Serres D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gaston De Serres sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gaston De Serres is affiliated with Université Laval in Canada and has contributed extensively to the field of medicine, focusing primarily on infectious diseases. Their research portfolio encompasses a range of studies addressing epidemiology, health, clinical psychology, and neurology, with a significant emphasis on SARS-CoV-2 and COVID-19-related investigations.

Their published work includes 258 contributions in medicine, among which 144 target infectious diseases, 45 cover epidemiology, 27 relate to health, 14 involve clinical psychology, and 12 pertain to neurology. Major topics in their research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 detection and testing
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • Influenza Virus Research Studies

De Serres has published frequently in notable venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Vaccine
  • Eurosurveillance
  • Infection Control and Hospital Epidemiology

Frequent collaborators consist of Sara Carazo (35 joint publications), Danuta M. Skowronski (31 joint publications), Denis Talbot (28 joint publications), Chantal Sauvageau (23 joint publications), and Nicholas Brousseau (21 joint publications).

Recent notable publications by De Serres include:

  • A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses, 2021, Cell Host & Microbe
  • Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada, 2022, Clinical Infectious Diseases
  • Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study, 2022, The Lancet Infectious Diseases
  • Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses, 2021, Cell Host & Microbe
  • Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study, 2022, The Lancet Infectious Diseases

Best Publications

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

    Danuta M Skowronski;Gaston De Serres

  • Human metapneumovirus infections in hospitalized children.

    Guy Boivin;Gaston De Serres;Stéphanie Côté;Rodica Gilca

  • Epidemiology of varicella zoster virus infection in Canada and the United Kingdom.

    M. Brisson;William Edmunds;B. Law

  • Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses

    Danuta M. Skowronski;Naveed Z. Janjua;Gaston De Serres;Suzana Sabaiduc

  • Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada

    Danuta M. Skowronski;Gaston De Serres;Natasha S. Crowcroft;Naveed Z. Janjua

  • Modelling the impact of immunization on the epidemiology of varicella zoster virus.

    M. Brisson;William Edmunds;B. Law

  • Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness

    Evan W Orenstein;Gaston De Serres;Michael J Haber;David K Shay

  • Repeated annual influenza vaccination and vaccine effectiveness: review of evidence

    Edward A. Belongia;Danuta M. Skowronski;Huong Q. McLean;Catharine Chambers

  • The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials.

    G De Serres;D M Skowronski;X W Wu;C S Ambrose

  • The changing age and seasonal profile of pertussis in Canada

    Danuta M. Skowronski;Gaston De Serres;Diane MacDonald;Diane MacDonald;Wrency Wu

  • An Outbreak of Severe Respiratory Tract Infection Due to Human Metapneumovirus in a Long-Term Care Facility

    Guy Boivin;Gaston De Serres;Marie-Eve Hamelin;Stéphanie Côté

  • Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

    Unknown

  • Rapid Decline of Influenza Vaccine—Induced Antibody in the Elderly: Is It Real, or Is It Relevant?

    Danuta M. Skowronski;S. Aleina Tweed;Gaston De Serres

  • Human Bocavirus Infections in Hospitalized Children and Adults

    Jean Longtin;Martine Bastien;Rodica Gilca;Eric Leblanc

  • Comparison of Risk Factors for Human Metapneumovirus and Respiratory Syncytial Virus Disease Severity in Young Children

    Jesse Papenburg;Jesse Papenburg;Marie-Ève Hamelin;Najwa Ouhoummane;Julie Carbonneau

  • Multiplex Real-Time PCR Assay for Detection of Influenza and Human Respiratory Syncytial Viruses

    Guy Boivin;Stéphanie Côté;Pierre Déry;Gaston De Serres

  • A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses.

    Alexandra Tauzin;Manon Nayrac;Mehdi Benlarbi;Shang Yu Gong

  • Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015

    Danuta M. Skowronski;Catharine Chambers;Gaston De Serres;Suzana Sabaiduc

  • Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

    Geneviève Deceuninck;Gaston De Serres;Gaston De Serres;Nicole Boulianne;Brigitte Lefebvre

  • Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations.

    Gaston De Serres;Noël Lampron;Jacques La Forge;Isabelle Rouleau

  • Component-Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007

    Danuta M. Skowronski;Gaston De Serres;Jim Dickinson;Martin Petric

Frequent Co-Authors

Danuta M. Skowronski
Danuta M. Skowronski University of British Columbia
Hugues Charest
Hugues Charest University of Montreal
Yan Li
Yan Li Public Health Agency of Canada
Guy Boivin
Guy Boivin Université Laval
Martin Petric
Martin Petric University of British Columbia
Nathalie Bastien
Nathalie Bastien Public Health Agency of Canada
Mel Krajden
Mel Krajden University of British Columbia
David W. Scheifele
David W. Scheifele University of British Columbia
Jonathan B. Gubbay
Jonathan B. Gubbay BC Children's Hospital Foundation
Scott A. Halperin
Scott A. Halperin Dalhousie University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology in the USA opens doors to various allied health professions, especially in nursing and patient care. Many students complement their immunology studies with practical healthcare qualifications that provide direct career pathways.

For those starting fresh, the best online BSN programs for non nurses offer a flexible route to enter the nursing field without prior experience. These programs prepare graduates to offer specialized care, including immunological treatments and patient support.

If speed and accessibility are priorities, some turn to the easiest accelerated nursing programs to get into. These pathways allow quicker transitions into nursing roles, which can be vital for those looking to integrate their immunology knowledge directly into clinical practice.

Starting with foundational roles, the easiest LPN programs to get into provide practical skills and patient care experience that complement immunological insights. From there, further advancement via easy nurse practitioner programs to get into can lead to more autonomous roles in healthcare, focusing on immunology-related specialties and broader patient care management.

Best Scientists Citing Gaston De Serres

Trending Scientists

Recently Published Articles